Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia

BACKGROUND: Acute myeloid leukemia (AML) is curable in a subset of cases. The DNA methylation regulator TET2 is frequently mutated in AML, and we hypothesized that studying TET2-specific differentially methylated CpGs (tet2-DMCs) improves AML classification. METHODS: We used bisulfite pyrosequencing...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Natl Cancer Inst
Autores principales: Yamazaki, Jumpei, Taby, Rodolphe, Jelinek, Jaroslav, Raynal, Noel J. M., Cesaroni, Matteo, Pierce, Sherry A., Kornblau, Steven M., Bueso-Ramos, Carlos E., Ravandi, Farhad, Kantarjian, Hagop M., Issa, Jean-Pierre J.
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4862435/
https://ncbi.nlm.nih.gov/pubmed/26568194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv323
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares